- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.03. | Genentech's TNKase Approved by FDA for Treatment of Strokes | ||
| 04.03. | FDA Approves Celltrion's Biosimilars Referencing Prolia and Xgeva | ||
| 04.03. | Mural Health, ICON Partner to Enhance Site Experience in Clinical Trials | ||
| 04.03. | Micreos, Northway Biotech Partner to Develop Scalable cGMP Production Processes | ||
| 04.03. | Bionova Scientific Opens New Facility in Fremont, CA | ||
| 04.03. | Repligen Acquires 908 Devices' Bioprocess Analytics Portfolio | ||
| 03.03. | Fresenius Kabi, Formycon Launch Otulfi in US | ||
| 03.03. | FDA Accepts GSK's Depemokimab for Review | ||
| 03.03. | Callio Therapeutics Launches with $187M Series A | ||
| 03.03. | Coronado Research Names Stephen Ralston EVP Market Access and Health Economics Outcomes Research | ||
| 03.03. | AbbVie and Gubra Partner to Develop GUB014295 for the Treatment of Obesity | ||
| 03.03. | Veranova Moves Headquarters to Devens, MA | ||
| 03.03. | Glenmark Acquires and Launches Acetylcysteine Injection | ||
| 28.02. | Tiziana Partners with Renaissance Lakewood to Scale Up Foralumab | ||
| 28.02. | Eisai Licenses Tasurgratinib to SciClone in Greater China Region | ||
| 28.02. | FDA Approves Fapon Biopharma's FP008 Cancer Therapy IND Application | ||
| 28.02. | Magnet Biomedicine & Lilly Partner on Molecular Glue Oncology Therapies | ||
| 27.02. | IPP Leases Fermentation Plant to Nuol for Green Chemicals | ||
| 27.02. | Sygnature Discovery Appoints New Chief Commercial Officer | ||
| 27.02. | ProRx Pharma Expands Production to Address Drug Shortages | ||
| 27.02. | Körber Pharma, AWS Partner on PAS-X MES in Life Sciences Manufacturing | ||
| 27.02. | FDA Grants Priority Review for Sobi's Gamifant in HLH/MAS | ||
| 27.02. | Veeva Adds Direct Data API to Veeva Vault Platform | ||
| 27.02. | Lilly Plans Four New Pharmaceutical Manufacturing Sites in the U.S. | ||
| 26.02. | Abzena Appoints Taylor Boyd as CBO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
